Explore more publications!
Healthy Living Maldives
Got News to Share?

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 25, 2025

CytomX Therapeutics to Present at Upcoming December Investor Conferences
November 25, 2025

CytomX Therapeutics to Present at Upcoming December Investor Conferences

Indeterminate GlobeNewswire
UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025

UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Compass Therapeutics to Participate in Upcoming December Investor Events
November 25, 2025

Compass Therapeutics to Participate in Upcoming December Investor Events

Indeterminate GlobeNewswire
Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
November 25, 2025

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania
November 25, 2025

Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania

Indeterminate GlobeNewswire
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
November 25, 2025

Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC

Indeterminate GlobeNewswire
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December
November 25, 2025

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December

Indeterminate GlobeNewswire
Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision’s LockeT Device
November 25, 2025

Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision’s LockeT Device

Indeterminate GlobeNewswire
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025

Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
November 25, 2025

Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
PetVivo Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-89%
November 25, 2025

PetVivo Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-89%

Indeterminate GlobeNewswire
Flare Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
November 25, 2025

Flare Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025
November 25, 2025

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

Indeterminate GlobeNewswire
BridgeBio to Participate in December Investor Conferences
November 25, 2025

BridgeBio to Participate in December Investor Conferences

Indeterminate GlobeNewswire
Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
November 25, 2025

Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

Indeterminate GlobeNewswire
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
November 25, 2025

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Indeterminate GlobeNewswire
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
November 25, 2025

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
November 25, 2025

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast Asia
November 25, 2025

Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast Asia

Indeterminate GlobeNewswire
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
November 25, 2025

Invivyd to Participate at the 8th Annual Evercore Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions